Günter Niegisch

32PUBLICATIONS
109CO-AUTHORS
Predictive and prognostic markersMajor global burdens of diseaseMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 09, 2026
Integrating NECTIN4 Amplification With Membranous Nectin-4 Expression to Develop a Scoring System for Predicting Enfortumab Vedotin Response in Urothelial Carcinoma.

|Apr 20, 2026
Clear Cell Renal Cell Carcinoma: Rare and Atypical Metastatic Localizations-A Case Series.

|Nov 26, 2025
Electronic Health Literacy, Psychological Distress, and Quality of Life in Urological Cancer Patients: A Longitudinal Study During Transition from Inpatient to Outpatient Care.

Dominik Fugmann, Steffen Holsteg, Ralf Schäfer

|Nov 11, 2025
Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107.

Jutta Schmitz, Anna L Bartkowiak, Michael Rose

|Jul 01, 2025
[Current and future treatment stratification of metastatic urothelial carcinoma: a great opportunity for true precision oncology].

Günter Niegisch, Stefanie Zschäbitz, Niklas Klümper

|Sep 14, 2024
Cabozantinib Plus Nivolumab in Adult Patients with Advanced or Metastatic Renal Cell Carcinoma: A Retrospective, Non-Interventional Study in a Real-World Cohort/GUARDIANS Project.

Thomas Hilser, Christopher Darr, Günter Niegisch

Pageof 6

Frequent Collaborators

14 joint publications

Michèle Janine Hoffmann

9 joint publications

Wolfgang A Schulz

7 joint publications

Patrick Petzsch

6 joint publications

Karl Köhrer